Advanced search
Publication Cover
Gut Microbes Volume 12, 2020 - Issue 1
Submit an article Journal homepage
12,242
Views
68
CrossRef citations to date
0
Altmetric
Review

Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis

Jessica Emily Greena IMPACT, the Institute for Mental and Physical Health and Clinical Translation, Food & Mood Centre, School of Medicine, Barwon Health, Deakin University, Geelong, Australia;b Monash Alfred Psychiatry Research Centre (Maprc), Central Clinical School, Faculty of Medicine Nursing and Health Sciences, Monash University, Melbourne, Australia;c Department of Psychiatry, Peninsula Health, Frankston, AustraliaCorrespondence[email protected]
View further author information
,
Jessica A. Davisa IMPACT, the Institute for Mental and Physical Health and Clinical Translation, Food & Mood Centre, School of Medicine, Barwon Health, Deakin University, Geelong, AustraliaView further author information
,
Michael Berka IMPACT, the Institute for Mental and Physical Health and Clinical Translation, Food & Mood Centre, School of Medicine, Barwon Health, Deakin University, Geelong, Australia;d Department of Psychiatry, University of Melbourne, Parkville, Australia;e Orygen Youth Health Research Centre and the Centre of Youth Mental Health, Melbourne, Australia;f The Florey Institute for Neuroscience and Mental Health, Parkville, Australia;g Barwon Health, Geelong, AustraliaORCID Iconhttps://orcid.org/0000-0002-5554-6946View further author information
ORCID Icon,
Christopher Hairg Barwon Health, Geelong, AustraliaView further author information
,
Amy Loughmana IMPACT, the Institute for Mental and Physical Health and Clinical Translation, Food & Mood Centre, School of Medicine, Barwon Health, Deakin University, Geelong, AustraliaORCID Iconhttps://orcid.org/0000-0002-0257-1443View further author information
ORCID Icon,
David Castled Department of Psychiatry, University of Melbourne, Parkville, Australia;h Department of Psychiatry, St Vincent’s Health, East Melbourne, AustraliaORCID Iconhttps://orcid.org/0000-0002-3075-1580View further author information
ORCID Icon,
Eugene Athana IMPACT, the Institute for Mental and Physical Health and Clinical Translation, Food & Mood Centre, School of Medicine, Barwon Health, Deakin University, Geelong, Australia;g Barwon Health, Geelong, Australia;i School of Medicine, Deakin University, Geelong, AustraliaView further author information
,
Andrew A. Nierenbergj Department of Psychiatry, Dauten Family Center for Bipolar Treatment Innovation, Boston, MA, USA;k Harvard Medical School, Boston, MA, USAView further author information
,
John F. Cryanl Department of Anatomy and Neuroscience, University College Cork and APC Microbiome, IrelandORCID Iconhttps://orcid.org/0000-0001-5887-2723View further author information
ORCID Icon,
Felice Jackaa IMPACT, the Institute for Mental and Physical Health and Clinical Translation, Food & Mood Centre, School of Medicine, Barwon Health, Deakin University, Geelong, Australia;m Centre for Adolescent Health, Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, Australia;n Black Dog Institute, Melbourne, Australia;o James Cook University, Townsville, AustraliaORCID Iconhttps://orcid.org/0000-0002-9825-0328View further author information
ORCID Icon &
Wolfgang Marxa IMPACT, the Institute for Mental and Physical Health and Clinical Translation, Food & Mood Centre, School of Medicine, Barwon Health, Deakin University, Geelong, AustraliaView further author information
 show all
Article: 1854640 | Received 09 Sep 2020, Accepted 11 Nov 2020, Published online: 19 Dec 2020

Citations (68)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Sarah-Jane Leigh, Caoimhe M.K. Lynch, Brian R. Healey Bird, Brendan T. Griffin, John F. Cryan & Gerard Clarke. (2022) Gut microbiota-drug interactions in cancer pharmacotherapies: implications for efficacy and adverse effects. Expert Opinion on Drug Metabolism & Toxicology 18:1, pages 5-26.
Read now
Kate R. Secombe, Ghanyah H. Al-Qadami, Courtney B. Subramaniam, Joanne M. Bowen, Jacqui Scott, Ysabella Z.A. Van Sebille, Matthew Snelson, Caitlin Cowan, Gerard Clarke, Cassandra E. Gheorghe, John F. Cryan & Hannah R. Wardill. (2021) Guidelines for reporting on animal fecal transplantation (GRAFT) studies: recommendations from a systematic review of murine transplantation protocols. Gut Microbes 13:1.
Read now

Articles from other publishers (66)

Amelia J. McGuinness, Lisa F. Stinson, Matthew Snelson, Amy Loughman, Andrea Stringer, Anthony J. Hannan, Caitlin S.M. Cowan, Hamdi A. Jama, Jose A. Caparros-Martin, Madeline L. West & Hannah R. Wardill. (2024) From hype to hope: Considerations in conducting robust microbiome science. Brain, Behavior, and Immunity 115, pages 120-130.
Crossref
Zhi-Luo Deng, Dietmar H. Pieper, Andreas Stallmach, Arndt Steube, Marius Vital, Michael Reck & Irene Wagner-Döbler. (2023) Engraftment of essential functions through multiple fecal microbiota transplants in chronic antibiotic-resistant pouchitis—a case study using metatranscriptomics. Microbiome 11:1.
Crossref
N. Jung, P. Schommers & C. Leisse. (2023) Präzisionsmedizin in der InfektiologiePrecision medicine in infectious diseases. Die Innere Medizin.
Crossref
Yuemeng Zhang, Xiaomei Wang, Wujuan Li, Yi Yang, Zhuoxuan Wu, Yuhong Lyu & Changwu Yue. (2023) Intestinal microbiota: a new perspective on delaying aging?. Frontiers in Microbiology 14.
Crossref
Qiushuang Zhu, Kai Wu, Qiuhong Yang, Bo Meng, Yucun Niu & Fenglian Zhao. (2023) Advances in psoriasis and gut microorganisms with co-metabolites. Frontiers in Microbiology 14.
Crossref
Xianzhuo Zhang, Xufei Luo, Liang Tian, Ping Yue, Mengyao Li, Kefeng Liu, Daoming Zhu, Chongfei Huang, Qianling Shi, Liping Yang, Zhili Xia, Jinyu Zhao, Zelong Ma, Jianlong Li, Joseph W. Leung, Yanyan Lin, Jinqiu Yuan, Wenbo Meng, Xun Li & Yaolong Chen. (2023) The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review. Frontiers in Microbiology 14.
Crossref
Yi Wang, Han Lai, Tian Zhang, Jing Wu, Huiling Tang, Xuanwei Liang, Dandan Ren, Jinzhu Huang & Weihong Li. (2023) Mitochondria of intestinal epithelial cells in depression: Are they at a crossroads of gut-brain communication?. Neuroscience & Biobehavioral Reviews 153, pages 105403.
Crossref
Amelia J. McGuinness, Amy Loughman, Jane A. Foster & Felice Jacka. (2023) Mood Disorders: The Gut Bacteriome and Beyond. Biological Psychiatry.
Crossref
Yu-Pei Zhuang, Hong-Li Zhou, Hai-Bin Chen, Ming-Yue Zheng, Yu-Wei Liang, Yu-Tian Gu, Wen-Ting Li, Wen-Li Qiu & Hong-Guang Zhou. (2023) Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application. Biomedicine & Pharmacotherapy 165, pages 115040.
Crossref
Xu Gu, Zhao-Hong Chen & Shu-Cheng Zhang. (2022) Fecal microbiota transplantation in childhood: past, present, and future. World Journal of Pediatrics 19:9, pages 813-822.
Crossref
Tahne Vongsavath, Tooba Laeeq, Kyaw Min Tun & Annie S. Hong. (2023) The Potential Role of Fecal Microbiota Transplantation in Parkinson’s Disease: A Systematic Literature Review. Applied Microbiology 3:3, pages 993-1002.
Crossref
Jinqiu Liu, Wei Zhu, Duncan James Lessing & Weihua Chu. (2023) Synthetic microbial consortia for the treatment of Clostridioides difficile infection in mice model . Microbial Biotechnology.
Crossref
Xin Wen, Rui Xie, Hong-Gang Wang, Min-Na Zhang, Le He, Meng-Hui Zhang & Xiao-Zhong Yang. (2023) Fecal microbiota transplantation alleviates experimental colitis through the Toll-like receptor 4 signaling pathway. World Journal of Gastroenterology 29:30, pages 4657-4670.
Crossref
Nicolas Benech & Harry Sokol. (2023) Targeting the gut microbiota in inflammatory bowel diseases: where are we?. Current Opinion in Microbiology 74, pages 102319.
Crossref
Jonas Mingaila, Alessandro Atzeni & Aurelijus Burokas. (2023) A Comparison of Methods of Gut Microbiota Transplantation for Preclinical Studies. International Journal of Molecular Sciences 24:15, pages 12005.
Crossref
Eva M. Medina-Rodriguez, Alyssa A. Cruz, Julia Cavati De Abreu & Eléonore Beurel. (2023) Stress, inflammation, microbiome and depression. Pharmacology Biochemistry and Behavior 227-228, pages 173561.
Crossref
Li Zecheng, Liu Donghai, Gu Runchuan, Qiao Yuan, Jin Qi, Zhang Yijia, Ran Shuaman, Liu Xiaoqi, Wang Yi, Mao Ni, Qin Yijin, Peng Liang & Wang Jun. (2023) Fecal microbiota transplantation in obesity metabolism: a META analysis and systematic review. Diabetes Research and Clinical Practice, pages 110803.
Crossref
Jianjun Yu, Jianhong Meng, Zhengwei Qin, Yuan Yu, Yingxin Liang, Yanjun Wang & Dongmei Min. (2023) Dysbiosis of gut microbiota inhibits NMNAT2 to promote neurobehavioral deficits and oxidative stress response in the 6-OHDA-lesioned rat model of Parkinson’s disease. Journal of Neuroinflammation 20:1.
Crossref
Jessica Emily Green, Michael Berk, Mohammadreza Mohebbi, Amy Loughman, Amelia J. McGuinness, David Castle, Mary Lou Chatterton, Joahna Perez, Philip Strandwitz, Eugene Athan, Christopher Hair, Andrew A. Nierenberg, John F. Cryan & Felice Jacka. (2023) Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial. The Canadian Journal of Psychiatry 68:5, pages 315-326.
Crossref
Amy Loughman, Christina J. Adler & Helen Macpherson. (2023) Unlocking Modifiable Risk Factors for Alzheimer’s Disease: Does the Oral Microbiome Hold Some of the Keys?. Journal of Alzheimer's Disease 92:4, pages 1111-1129.
Crossref
Julia A. Bespyatykh, Alina V. Gospodarik, Evgeny A. Zhuravel, George Z. Seregin, Anastacia V. Komarova, Sulejman S. Esiev, Gleb O. Bronin & Yaroslab D. Shansky. (2023) Fecal microbiota transplantation in the treatment of astrovirus infection in a recipient of an allogeneic hematopoietic stem cell transplant: a clinical case. Journal of Clinical Practice 14:1, pages 115-122.
Crossref
Hon-Yen Wu, Yi-Tsung Lin, Wan-Chuan Tsai, Yen-Ling Chiu, Mei-Ju Ko, Ju-Yeh Yang, Mei-Fen Pai, Hsin-Sui Hsu, Shih-Ping Hsu, Yu-Sen Peng & Chun-Hsing Liao. (2023) Microbiota analysis in the hemodialysis population - Focusing on Enterobacteriaceae. Journal of Microbiology, Immunology and Infection 56:2, pages 311-323.
Crossref
Niklas Grüner, Anna Lisa Ortlepp & Jochen Mattner. (2023) Pivotal Role of Intestinal Microbiota and Intraluminal Metabolites for the Maintenance of Gut–Bone Physiology. International Journal of Molecular Sciences 24:6, pages 5161.
Crossref
Ajay S. Gulati, Maribeth R. Nicholson, Alexander Khoruts & Stacy A. Kahn. (2023) Fecal Microbiota Transplantation Across the Lifespan: Balancing Efficacy, Safety, and Innovation. American Journal of Gastroenterology 118:3, pages 435-439.
Crossref
Lucy Hocking, Gianluca Ianiro, Rupert W. Leong, Tariq Iqbal, Dina Kao, Mark Cabling, Stephanie Stockwell, Robert J. Romanelli & Sonja Marjanovic. (2022) Faecal microbiota transplantation for recurrent C. difficile infections: challenges and improvement opportunities for clinical practice and healthcare systems . Alimentary Pharmacology & Therapeutics 57:5, pages 549-564.
Crossref
Junli Ma, Zekun Liu, Xinxin Gao, Yiyang Bao, Ying Hong, Xiaofang He, Weize Zhu, Yan Li, Wenjin Huang, Ningning Zheng, Lili Sheng, Ben Zhou, Hongzhuan Chen & Houkai Li. (2023) Gut microbiota remodeling improves natural aging-related disorders through Akkermansia muciniphila and its derived acetic acid. Pharmacological Research 189, pages 106687.
Crossref
Biao Zou, Shengxuan Liu, Xuesong Li, Jiayi He, Chen Dong, Mengling Ruan, Zhihua Huang & Sainan Shu. (2023) Repeated and multiple fecal microbiota transplantations plus partial enteral nutrition as the first-line treatment in active pediatric Crohn’s disease. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Tânia Rodrigues, Sofia Rodrigues Fialho, João Ricardo Araújo, Rita Rocha & André Moreira-Rosário. (2023) Procedures in Fecal Microbiota Transplantation for Treating Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. Journal of Clinical Medicine 12:5, pages 1725.
Crossref
Beata Kasztelan-Szczerbinska, Anna Rycyk-Bojarzynska, Agnieszka Szczerbinska & Halina Cichoz-Lach. (2023) Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies—A Critical Overview. Nutrients 15:3, pages 760.
Crossref
Connor Campbell, Mrunmayee R. Kandalgaonkar, Rachel M. Golonka, Beng San Yeoh, Matam Vijay-Kumar & Piu Saha. (2023) Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy. Biomedicines 11:2, pages 294.
Crossref
Jessica E. Green, Amelia J. McGuinness, Michael Berk, David Castle, Eugene Athan, Christopher Hair, Philip Strandwitz, Amy Loughman, Andrew A. Nierenberg, John F. Cryan, Mohammadreza Mohebbi & Felice Jacka. (2023) Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial. Pilot and Feasibility Studies 9:1.
Crossref
Shaodong Hao, Shanshan Yang, Naiwei Zhang & Hongjie Cheng. (2023) Fecal Microbiota Transplantation Research over the Past Decade: Current Status and Trends. Canadian Journal of Infectious Diseases and Medical Microbiology 2023, pages 1-18.
Crossref
Mariano A. Molina, Willem J.G. Melchers, Karolina M. Andralojc, William P.J. Leenders & Martijn A. Huynen. (2023) Longitudinal analysis on the ecological dynamics of the cervicovaginal microbiome in hrHPV infection. Computational and Structural Biotechnology Journal 21, pages 4424-4431.
Crossref
Amar Singh, Sujata Prasad & Gatikrushna Singh. 2023. Microbiome Therapeutics. Microbiome Therapeutics 443 475 .
Zhiqiang Huang, Kun Liu, Wenwen Ma, Dezhi Li, Tianlu Mo & Qing Liu. (2022) The gut microbiome in human health and disease—Where are we and where are we going? A bibliometric analysis. Frontiers in Microbiology 13.
Crossref
Sevag Hamamah, Roxana Gheorghita, Andrei Lobiuc, Ioan-Ovidiu Sirbu & Mihai Covasa. (2022) Fecal microbiota transplantation in non-communicable diseases: Recent advances and protocols. Frontiers in Medicine 9.
Crossref
Nicolas Benech & Laetitia Koppe. (2022) Is there a place for faecal microbiota transplantation in chronic kidney disease?. Nephrology Dialysis Transplantation 37:12, pages 2303-2306.
Crossref
Georgia Brown, Emily C. Hoedt, Simon Keely, Ayesha Shah, Marjorie M. Walker, Gerald Holtmann & Nicholas J. Talley. (2022) Role of the duodenal microbiota in functional dyspepsia. Neurogastroenterology & Motility 34:11.
Crossref
Yuan-Wei Zhang, Mu-Min Cao, Ying-Juan Li, Pan-Pan Lu, Guang-Chun Dai, Ming Zhang, Hao Wang & Yun-Feng Rui. (2022) Fecal microbiota transplantation ameliorates bone loss in mice with ovariectomy-induced osteoporosis via modulating gut microbiota and metabolic function. Journal of Orthopaedic Translation 37, pages 46-60.
Crossref
Pei-Jun Ma, Meng-Meng Wang & Yun Wang. (2022) Gut microbiota: A new insight into lung diseases. Biomedicine & Pharmacotherapy 155, pages 113810.
Crossref
Yu Li, Yaobin Ouyang & Cong He. (2022) Research trends on clinical fecal microbiota transplantation: A biliometric analysis from 2001 to 2021. Frontiers in Immunology 13.
Crossref
Biao Zou, Sheng-Xuan Liu, Xue-Song Li, Jia-Yi He, Chen Dong, Meng-Ling Ruan, Lei Xu, Tao Bai, Zhi-Hua Huang & Sai-Nan Shu. (2022) Long-term safety and efficacy of fecal microbiota transplantation in 74 children: A single-center retrospective study. Frontiers in Pediatrics 10.
Crossref
Liuting Zeng, Ying Deng, Kailin Yang, Junpeng Chen, Qi He & Hua Chen. (2022) Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: A systematic review and meta-analysis. Frontiers in Immunology 13.
Crossref
Gianluca Ianiro, Michal Punčochář, Nicolai Karcher, Serena Porcari, Federica Armanini, Francesco Asnicar, Francesco Beghini, Aitor Blanco-Míguez, Fabio Cumbo, Paolo Manghi, Federica Pinto, Luca Masucci, Gianluca Quaranta, Silvia De Giorgi, Giusi Desirè Sciumè, Stefano Bibbò, Federica Del Chierico, Lorenza Putignani, Maurizio Sanguinetti, Antonio Gasbarrini, Mireia Valles-Colomer, Giovanni Cammarota & Nicola Segata. (2022) Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases. Nature Medicine 28:9, pages 1913-1923.
Crossref
Qin Xu, Dan Li, Jing Chen, Ju Yang, Jiai Yan, Yanping Xia, Feng Zhang, Xuesong Wang & Hong Cao. (2022) Crosstalk between the gut microbiota and postmenopausal osteoporosis: Mechanisms and applications. International Immunopharmacology 110, pages 108998.
Crossref
Mancai Wang, Xiaofeng Xie, Songbo Zhao, Wei Han & Youcheng Zhang. (2022) Global research trends and hotspots of fecal microbiota transplantation: A bibliometric and visualization study. Frontiers in Microbiology 13.
Crossref
Atsushi Nishida, Kyohei Nishino, Masashi Ohno, Keitaro Sakai, Yuji Owaki, Yoshika Noda & Hirotsugu Imaeda. (2022) Update on gut microbiota in gastrointestinal diseases. World Journal of Clinical Cases 10:22, pages 7653-7664.
Crossref
Shigui Xue, Yan Xue, Danbo Dou, Huan Wu, Ping Zhang, Yang Gao, Yini Tang, Zehua Xia, Sen Yang & Sizhen Gu. (2022) Kui Jie Tong Ameliorates Ulcerative Colitis by Regulating Gut Microbiota and NLRP3/Caspase-1 Classical Pyroptosis Signaling Pathway. Disease Markers 2022, pages 1-15.
Crossref
Carolina Gubert, Jocelyn M Choo, Chloe J Love, Saritha Kodikara, Bethany A Masson, Jamie J M Liew, Yiwen Wang, Geraldine Kong, Vinod K Narayana, Thibault Renoir, Kim Anh Lê Cao, Geraint B Rogers & Anthony J Hannan. (2022) Faecal microbiota transplant ameliorates gut dysbiosis and cognitive deficits in Huntington’s disease mice. Brain Communications 4:4.
Crossref
Lie Zheng, Yong-Yi Ji, Xin-Li Wen & Sheng-Lei Duan. (2022) Fecal microbiota transplantation in the metabolic diseases: Current status and perspectives. World Journal of Gastroenterology 28:23, pages 2546-2560.
Crossref
Chunlan Huang, Qixiang Mei, Lihong Lou, Zehua Huang, Yang Fu, Junjie Fan, Jingjing Wang, Nuoming Yin, Yi Zheng, Yingying Lu & Yue Zeng. (2022) Ulcerative Colitis in Response to Fecal Microbiota Transplantation via Modulation of Gut Microbiota and Th17/Treg Cell Balance. Cells 11:11, pages 1851.
Crossref
Ya-Ting Wu, Shou-Ju Shen, Kuan-Fu Liao & Ching-Ying Huang. (2022) Dietary Plant and Animal Protein Sources Oppositely Modulate Fecal Bilophila and Lachnoclostridium in Vegetarians and Omnivores . Microbiology Spectrum 10:2.
Crossref
A. J. McGuinness, J. A. Davis, S. L. Dawson, A. Loughman, F. Collier, M. O’Hely, C. A. Simpson, J. Green, W. Marx, C. Hair, G. Guest, M. Mohebbi, M. Berk, D. Stupart, D. Watters & F. N. Jacka. (2022) A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia. Molecular Psychiatry 27:4, pages 1920-1935.
Crossref
Yuanyuan Gu, Guannan Zhou, Fangyue Zhou, Yao Li, Qiongwei Wu, Hongyu He, Yi Zhang, Chengbin Ma, Jingxin Ding & Keqin Hua. (2022) Gut and Vaginal Microbiomes in PCOS: Implications for Women’s Health. Frontiers in Endocrinology 13.
Crossref
Frederik Cold, Camilla Kara Svensson, Andreas Munk Petersen, Lars Hestbjerg Hansen & Morten Helms. (2022) Long-Term Safety Following Faecal Microbiota Transplantation as a Treatment for Recurrent Clostridioides difficile Infection Compared with Patients Treated with a Fixed Bacterial Mixture: Results from a Retrospective Cohort Study. Cells 11:3, pages 435.
Crossref
Jongwook Yu & Jae Hee Cheon. (2022) Microbial Modulation in Inflammatory Bowel Diseases. Immune Network 22:6.
Crossref
Mengfan Li, Lijiao Yang, Chenlu Mu, Yue Sun, Yu Gu, Danfeng Chen, Tianyu Liu & Hailong Cao. (2022) Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives. Computational and Structural Biotechnology Journal 20, pages 2402-2414.
Crossref
Kirsi Laitinen, Kati Mokkala & Marko Kalliomäki. 2022. Early Nutrition and Long-Term Health. Early Nutrition and Long-Term Health 229 256 .
Jessica E. Green, Michael Berk, Amy Loughman, Wolfgang Marx, David Castle, Amelia J. McGuinness, John F. Cryan, Andrew A. Nierenberg, Eugene Athan, Christopher Hair & Felice Jacka. (2021) FMT for psychiatric disorders: Following the brown brick road into the future. Bipolar Disorders 23:7, pages 651-655.
Crossref
Bo Yang, Hongliang Tian, Chen Ye, Zhiliang Lin, Di Zhao, Chunlian Ma, Jiangman Zhao, Shouxin Wu, Rongfeng Jiang, Ning Li, Huanlong Qin & Qiyi Chen. (2021) The Efficacy and Safety of Fecal Microbiota Transplantation Combined With Biofeedback for Mixed Constipation: A Retrospective Cohort Study. Frontiers in Medicine 8.
Crossref
Hannah R. Wardill, Stijn A.R. van der Aa, Ana R. da Silva Ferreira, Rick Havinga, Wim J.E. Tissing & Hermie J.M. Harmsen. (2021) Antibiotic-induced disruption of the microbiome exacerbates chemotherapy-induced diarrhoea and can be mitigated with autologous faecal microbiota transplantation. European Journal of Cancer 153, pages 27-39.
Crossref
Magdy El-Salhy, Tanisa Patcharatrakul & Sutep Gonlachanvit. (2021) Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21 st century . World Journal of Gastroenterology 27:22, pages 2921-2943.
Crossref
Manuel Ponce-Alonso, Carlota García-Hoz, Ana Halperin, Javier Nuño, Pilar Nicolás, Adolfo Martínez-Pérez, Juan Ocaña, Juan Carlos García-Pérez, Antonio Guerrero, Antonio López-Sanromán, Rafael Cantón, Garbiñe Roy & Rosa del Campo. (2021) An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis. Frontiers in Immunology 12.
Crossref
M. Fidelle, L. Derosa, B. Routy & L. Zitvogel. (2021) Contourner la résistance à l’immunothérapie des cancers : interventions centrées sur le microbiome intestinal. Bulletin de l'Académie Nationale de Médecine 205:4, pages 364-382.
Crossref
M. M. Bakalchuk. (2021) FECAL MICROBIOTES TRANSPLANTATION TECHNOLOGIES: MEDICAL, BIOTECHNOLOGICAL AND REGULATORY ASPECTS. Biotechnologia Acta 14:1, pages 46-56.
Crossref
Frederik Cold, Simon Mark Dahl Baunwall, Jens Frederik Dahlerup, Andreas Munk Petersen, Christian Lodberg Hvas & Lars Hestbjerg Hansen. (2021) Systematic review with meta-analysis: encapsulated faecal microbiota transplantation – evidence for clinical efficacy. Therapeutic Advances in Gastroenterology 14, pages 175628482110410.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.